data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Adaptive Biotechnologies
(NASDAQ:ADPT)
$8.265
0.145[1.79%]
Last update: 12:05PM (Delayed 15-Minutes)
Get Real Time Here
Day Range8.12 - 8.3252 Wk Range5.96 - 28.92Open / Close8.12 / -Float / Outstanding97.1M / 143M
Vol / Avg.244.5K / 1MMkt Cap1.2BP/E-50d Avg. Price7.51
Div / Yield-Payout Ratio-Total Float97.1MEPS-0.32

Adaptive Biotechnologies Stock (NASDAQ:ADPT), Quotes and News Summary

Adaptive Biotechnologies Stock (NASDAQ: ADPT) stock price, news, charts, stock research, profile.

Day Range8.12 - 8.3252 Wk Range5.96 - 28.92Open / Close8.12 / -Float / Outstanding97.1M / 143M
Vol / Avg.244.5K / 1MMkt Cap1.2BP/E-50d Avg. Price7.51
Div / Yield-Payout Ratio-Total Float97.1MEPS-0.32
Bhavik Nair - Aug 26, 2022, 6:00AM
Henry Khederian - Jun 15, 2022, 2:50PM
Rachit Vats - Mar 24, 2022, 10:00PM
Vandana Singh - Mar 9, 2022, 10:37AM
Vandana Singh - Feb 16, 2022, 12:02PM
Globe Newswire - 6 days ago
Globe Newswire - Nov 21, 2022, 7:30AM
Globe Newswire - Nov 3, 2022, 4:05PM
Globe Newswire - Oct 11, 2022, 8:05AM
Globe Newswire - Oct 5, 2022, 4:05PM
Globe Newswire - Sep 12, 2022, 8:30AM
Globe Newswire - Sep 2, 2022, 8:00AM
Globe Newswire - Aug 3, 2022, 4:05PM
Globe Newswire - Jul 28, 2022, 7:30AM
Globe Newswire - Jul 8, 2022, 4:05PM
Globe Newswire - Jun 15, 2022, 7:30AM
Globe Newswire - Jun 2, 2022, 4:10PM
Globe Newswire - May 26, 2022, 8:00AM
Business Wire - May 24, 2022, 8:00AM
Globe Newswire - May 4, 2022, 4:05PM
Globe Newswire - May 2, 2022, 4:05PM
Globe Newswire - Apr 5, 2022, 4:30PM
Globe Newswire - Mar 9, 2022, 7:00AM
PRNewswire - Mar 7, 2022, 8:00AM
Globe Newswire - Mar 2, 2022, 4:05PM
Globe Newswire - Feb 18, 2022, 11:35AM
Globe Newswire - Feb 15, 2022, 4:05PM
Globe Newswire - Feb 2, 2022, 4:05PM
Globe Newswire - Jan 24, 2022, 4:05PM
Globe Newswire - Jan 10, 2022, 8:30AM
Globe Newswire - Jan 4, 2022, 4:05PM
Globe Newswire - Dec 29, 2021, 8:00AM
Globe Newswire - Dec 13, 2021, 4:05PM
Globe Newswire - Dec 2, 2021, 8:00AM
InvestorsObserver - Nov 18, 2022, 11:08AM
InvestorsObserver - Nov 10, 2022, 12:08PM
InvestorsObserver - Nov 8, 2022, 12:25PM
InvestorsObserver - Nov 7, 2022, 1:17PM
InvestorsObserver - Nov 7, 2022, 1:04PM
TipRanks - Nov 7, 2022, 7:08AM
TipRanks - Nov 6, 2022, 10:45PM
InvestorPlace - Nov 4, 2022, 5:16PM
InvestorsObserver - Nov 4, 2022, 2:43PM
Seeking Alpha - Nov 3, 2022, 10:36PM
Seeking Alpha - Oct 21, 2022, 7:19AM
InvestorsObserver - Oct 19, 2022, 1:11PM
InvestorsObserver - Oct 18, 2022, 12:23PM
InvestorsObserver - Oct 17, 2022, 1:04PM
Seeking Alpha - Oct 11, 2022, 9:48AM
InvestorsObserver - Oct 7, 2022, 3:19PM
InvestorsObserver - Oct 4, 2022, 12:45PM
InvestorsObserver - Sep 22, 2022, 3:27PM
Seeking Alpha - Sep 19, 2022, 5:43AM
InvestorsObserver - Sep 16, 2022, 10:27AM
Seeking Alpha - Sep 12, 2022, 8:40AM
InvestorsObserver - Sep 6, 2022, 1:47PM
InvestorsObserver - Sep 2, 2022, 1:09PM
InvestorsObserver - Aug 30, 2022, 3:26PM
InvestorsObserver - Aug 26, 2022, 3:18PM
InvestorsObserver - Aug 25, 2022, 10:02AM
Seeking Alpha - Aug 25, 2022, 8:29AM
TipRanks - Aug 5, 2022, 12:38AM
InvestorsObserver - Aug 4, 2022, 12:17PM
Seeking Alpha - Aug 4, 2022, 7:17AM
Seeking Alpha - Aug 3, 2022, 9:29PM
Seeking Alpha - Aug 2, 2022, 5:35PM
Seeking Alpha - Aug 2, 2022, 5:35PM
Seeking Alpha - Jul 31, 2022, 7:31AM
InvestorsObserver - Jul 20, 2022, 11:57AM
Sector: Health Care.Industry: Life Sciences Tools & Services
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-14
REV
Q3 2022Est.ActualSurprise
EPS-0.370-0.320 0.0500
REV48.670M47.830M-840.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Adaptive Biotechnologies (ADPT) stock?

A

You can purchase shares of Adaptive Biotechnologies (NASDAQ: ADPT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Adaptive Biotechnologies's (ADPT) competitors?

Q

What is the target price for Adaptive Biotechnologies (ADPT) stock?

A

The latest price target for Adaptive Biotechnologies (NASDAQ: ADPT) was reported by Morgan Stanley on Monday, November 7, 2022. The analyst firm set a price target for 16.00 expecting ADPT to rise to within 12 months (a possible 93.59% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Adaptive Biotechnologies (ADPT)?

A

The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $8.265 last updated Today at November 28, 2022, 5:05 PM UTC.

Q

Does Adaptive Biotechnologies (ADPT) pay a dividend?

A

There are no upcoming dividends for Adaptive Biotechnologies.

Q

When is Adaptive Biotechnologies (NASDAQ:ADPT) reporting earnings?

A

Adaptive Biotechnologies’s Q4 earnings are confirmed for Tuesday, February 14, 2023.

Q

Is Adaptive Biotechnologies (ADPT) going to split?

A

There is no upcoming split for Adaptive Biotechnologies.

Q

What sector and industry does Adaptive Biotechnologies (ADPT) operate in?

A

Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.